Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Study Information
Alliance Study ID: NCCTG-N09C6
NCT Study ID (ClinicalTrials.gov): NCT01156142
Alliance Committee: Cancer Control
Disease or Cancer Type: Head & Neck Cancers
Alliance Study Chair: Robert C. Miller, MD
Status: COMPLETED
Study Description
RATIONALE: Doxepin hydrochloride may be an effective treatment for oral mucositis pain in patients undergoing radiation therapy with or without chemotherapy.
PURPOSE: This randomized phase III trial is studying doxepin hydrochloride to see how well it works compared to placebo in treating oral mucositis pain in patients with head and neck cancer undergoing radiation therapy with or without chemotherapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information